Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Editorial: just how "difficult" is it to withdraw PPI treatment?

Howden CW, Kahrilas PJ.

Am J Gastroenterol. 2010 Jul;105(7):1538-40. doi: 10.1038/ajg.2010.91.

PMID:
20606660
2.

It is difficult to discontinue PPI treatment in patients with GERD.

Bjornsson E.

Am J Gastroenterol. 2011 Feb;106(2):367-8; author reply 368. doi: 10.1038/ajg.2010.402. No abstract available.

PMID:
21301460
3.

Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?

Juul-Hansen P, Rydning A.

Scand J Gastroenterol. 2011 Apr;46(4):398-405. doi: 10.3109/00365521.2010.537684. Epub 2010 Dec 9.

PMID:
21142586
4.

Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.

Emerson CR, Marzella N.

Clin Ther. 2010 Aug;32(9):1578-96. doi: 10.1016/j.clinthera.2010.08.008. Review.

PMID:
20974316
5.

Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.

van der Pol RJ, Smits MJ, van Wijk MP, Omari TI, Tabbers MM, Benninga MA.

Pediatrics. 2011 May;127(5):925-35. doi: 10.1542/peds.2010-2719. Epub 2011 Apr 4. Review.

PMID:
21464183
6.

Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial.

Niklasson A, Lindström L, Simrén M, Lindberg G, Björnsson E.

Am J Gastroenterol. 2010 Jul;105(7):1531-7. doi: 10.1038/ajg.2010.81. Epub 2010 Mar 23.

PMID:
20332770
7.

Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure.

Strid H, Fjell A, Simrén M, Björnsson ES.

Eur J Gastroenterol Hepatol. 2009 Feb;21(2):137-42. doi: 10.1097/MEG.0b013e3283200047.

PMID:
19212202
8.
9.

Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment.

Lødrup AB, Reimer C, Bytzer P.

Scand J Gastroenterol. 2013 May;48(5):515-22. doi: 10.3109/00365521.2012.746395. Epub 2013 Jan 14. Review.

PMID:
23311977
10.

Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.

Bytzer P, van Zanten SV, Mattsson H, Wernersson B.

Aliment Pharmacol Ther. 2012 Oct;36(7):635-43. doi: 10.1111/apt.12007. Epub 2012 Aug 1.

11.

Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.

Devault KR.

Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):197-205. doi: 10.1586/17474124.1.2.197. Review.

PMID:
19072410
12.

Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat.

McColl KE, Gillen D.

Gastroenterology. 2009 Jul;137(1):20-2. doi: 10.1053/j.gastro.2009.05.015. Epub 2009 May 29. No abstract available.

PMID:
19482105
13.

Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis.

Illueca M, Wernersson B, Henderson C, Lundborg P.

J Pediatr Gastroenterol Nutr. 2010 Dec;51(6):733-40. doi: 10.1097/MPG.0b013e3181e2acfd. Review.

PMID:
20808247
14.

Dexlansoprazole for the treatment of esophagitis and GERD.

Davies SL.

Drugs Today (Barc). 2010 Feb;46(2):75-80. doi: 10.1358/dot.2010.46.2.1437714.

PMID:
20393635
15.

Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?

Bruley des Varannes S, Coron E, Galmiche JP.

Best Pract Res Clin Gastroenterol. 2010 Dec;24(6):905-21. doi: 10.1016/j.bpg.2010.09.004. Review.

PMID:
21126703
16.
17.

Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.

Miner PB Jr, McKean LA, Gibb RD, Erasala GN, Ramsey DL, McRorie JW.

Aliment Pharmacol Ther. 2010 Apr;31(8):846-51. doi: 10.1111/j.1365-2036.2010.04258.x. Epub 2010 Feb 8.

18.

Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.

Furuta T, Shimatani T, Sugimoto M, Ishihara S, Fujiwara Y, Kusano M, Koike T, Hongo M, Chiba T, Kinoshita Y; Acid-Related Symptom Research Group.

J Gastroenterol. 2011 Nov;46(11):1273-83. doi: 10.1007/s00535-011-0446-2. Epub 2011 Aug 24.

PMID:
21861141
19.

pH, healing rate, and symptom relief in patients with GERD.

Huang JQ, Hunt RH.

Yale J Biol Med. 1999 Mar-Jun;72(2-3):181-94. Review.

20.

Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy.

Reimer C, Søndergaard B, Hilsted L, Bytzer P.

Gastroenterology. 2009 Jul;137(1):80-7, 87.e1. doi: 10.1053/j.gastro.2009.03.058. Epub 2009 Apr 10.

PMID:
19362552
Items per page

Supplemental Content

Write to the Help Desk